GSK Plc said it won US approval for a drug to treat severe asthma, boosting its prospects as a potential blockbuster.

French drugmaker Sanofi on Monday flagged another delay to a U.S. regulatory decision for its experimental multiple sclerosis drug and reported disappointing results from a late-stage study, sending shares of the company down 2%.

Medetomidine, a veterinary sedative, mixed into fentanyl has sent thousands to hospitals, not only for overdose but for life-threatening withdrawal. It is spreading to other cities.

FDA approves Addyi for low sexual desire in postmenopausal women under 65, expanding use beyond premenopausal patients for the first time.

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's Enhertu in combination with Roche's drug, Perjeta, for the first-line treatment of patients with a type of breast cancer,

Physicians stand to earn big money when signing up patients for drug trials. And lately, some of those trials have been producing dubious science.

A little-known provision in the Affordable Care Act allows patients to ask state-run panels to review decisions made by health insurance providers.

A study from the University of Maryland, Baltimore County (UMBC), published in Nature Communications, reveals how enteroviruses—including pathogens that cause polio, encephalitis, myocarditis, and the common cold—initiate replication by hijacking host-cell machinery.

Indiana has launched two new dashboards aimed at tracking drug overdose data and violent crimes. Advocates say the overdose data improves on the states previous dashboard.